Future Science Group期刊
Future Science Group期刊
期刊
会议
图书
×
筛选
期刊分组
出版时间
学科领域
导出到 
排序方式 :
最新发表 
共29,794条
Targeting the PSGL-1 pathway for immune modulation
作者：Roberto Tinoco , Linda M Bradley
来源：[J].Immunotherapy(IF 2.393), 2017, Vol.9 (10), pp.785-788Future Science Group
全文获取
纸质馆藏
    Case report: pembrolizumab-induced Type 1 diabetes in a patient with metastatic cholangiocarcinoma
    作者：Matthew A Smith-Cohn , David Gill , Benjamin N Voorhies ...
    来源：[J].Immunotherapy(IF 2.393), 2017, Vol.9 (10), pp.797-804Future Science Group
    摘要：Background: Immune checkpoint inhibitors are novel cancer therapies associated with numerous autoimmune toxicities, some of which are only now being appreciated. Case presentation: A 67-year old female with metastatic cholangiocarcinoma and no prior history of diabetes was treate...
    全文获取
    纸质馆藏
      Five new therapies or just one new treatment? A critical look at immune checkpoint inhibition in urothelial cancer
      作者：Amishi Y Shah , Jianjun Gao , Arlene O Siefker-Radtke
      来源：[J].Immunotherapy(IF 2.393), 2017, Vol.9 (10), pp.781-784Future Science Group
      全文获取
      纸质馆藏
        Advances in biomaterial design and application for medical intervention
        作者：May Azzawi
        来源：[J].Nanomedicine (Lond.)(IF 5.26), 2017, Vol.12 (18), pp.2151-2152Future Science Group
        全文获取
        纸质馆藏
          Certolizumab, an anti-TNF safe during pregancy? The CRIB Study results: an interview with Professor Xavier Mariette
          作者：Xavier Mariette
          来源：[J].Immunotherapy(IF 2.393), 2017, Vol.9 (10), pp.793-795Future Science Group
          摘要：Professor Xavier Mariette, MD, PhD, has served as the Head of the Rheumatology Department of Bicêtre Hospital, Paris-Sud University since 1999, a role he took following 10 years of practice of clinical immunology. Professor Mariette has initiated a number of clinical resear...
          全文获取
          纸质馆藏
            Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy
            作者：Saeid Zanganeh , Ryan Spitler , Gregor Hutter ...
            来源：[J].Immunotherapy(IF 2.393), 2017, Vol.9 (10), pp.819-835Future Science Group
            摘要：The success of any given cancer immunotherapy relies on several key factors. In particular, success hinges on the ability to stimulate the immune system in a controlled and precise fashion, select the best treatment options and appropriate therapeutic agents, and use highly effec...
            全文获取
            纸质馆藏
              Two is better than one: advances in pathogen-boosted immunotherapy and adoptive T-cell therapy
              作者：Gang Xin , David M Schauder , Ryan Zander ...
              来源：[J].Immunotherapy(IF 2.393), 2017, Vol.9 (10), pp.837-849Future Science Group
              摘要：The recent tremendous successes in clinical trials take cancer immunotherapy into a new era and have attracted major attention from both academia and industry. Among the variety of immunotherapy strategies developed to boost patients’ own immune systems to fight against mal...
              全文获取
              纸质馆藏
                Application of chimeric antigen receptor-engineered T cells in ovarian cancer therapy
                作者：Minghui Zhang , Dr. Bin Zhang , Huirong Shi
                来源：[J].Immunotherapy(IF 2.393), 2017, Vol.9 (10), pp.851-861Future Science Group
                摘要：Due to the critical role of T cells in the immune surveillance of ovarian cancer, adoptive T-cell therapies are receiving increased attention as an immunotherapeutic approach for ovarian cancer. Chimeric antigen receptors (CARs), constructed by incorporating the single-chain Fv f...
                全文获取
                纸质馆藏
                  Corrigendum
                  来源：[J].Immunotherapy(IF 2.393), 2017, Vol.9 (10), pp.863-863Future Science Group
                  全文获取
                  纸质馆藏
                    FOCIS goes south: advances in translational and clinical immunology
                    作者：Alexis M Kalergis , Ignacio Anegon , Pablo A Gonzá ...
                    来源：[J].Immunotherapy(IF 2.393), 2017, Vol.9 (10), pp.789-792Future Science Group
                    摘要：FOCIS goes South: Advances in Translational and Clinical Immunology was the first Federation of Clinical Immunology Societies (FOCIS) ( www.focisnet.org ) meeting held in Latin America (May 15–17, 2017, Santiago de Chile, Chile). The meeting was organized as a 3-day workshop...
                    全文获取
                    纸质馆藏
                      12345678910下页

                      我们正在为您处理中，这可能需要一些时间，请稍等。

                      资源合作：cnki.scholar@cnki.net,　+86-10-82896619　　 意见反馈：scholar@cnki.net

                      ×